Austar Lifesciences Limited provided group earnings guidance for the year ended 31 December 2021. The group is expected to record a profit attributable to the owners of the Company of not less than RMB 270 million for the year ended 31 December 2021, as compared to the profit attributable to the owners of the Company of approximately RMB 33.1 million for the year ended 31 December 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.77 HKD | +2.67% | -10.47% | -50.64% |
26/03 | Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
22/01 | Austar Lifesciences to Swing to Loss; Shares Drop | MT |
1st Jan change | Capi. | |
---|---|---|
-50.64% | 49.22M | |
-6.21% | 180B | |
-0.08% | 108B | |
-3.09% | 68.29B | |
-4.84% | 46.96B | |
+12.85% | 45.64B | |
+7.77% | 42.41B | |
+19.71% | 31.01B | |
+16.55% | 25.51B | |
-7.44% | 23.17B |
- Stock Market
- Equities
- 6118 Stock
- News Austar Lifesciences Limited
- Austar Lifesciences Limited Provides Group Earnings Guidance for the Year Ended 31 December 2021